17 years' of EBRT plus HDR brachytherapy boost in high risk localized prostate cancer patients

被引：0
|
作者：
Vigneault, E. [1 ]
Carignan, D. [2 ]
Magnan, S. [1 ]
Froment, M. [1 ]
Foster, W. [1 ]
Aubin, S. [1 ]
Lavallee, M. [1 ]
Lacroix, F. [1 ]
Cantin, A. [1 ]
Poulin, E. [1 ]
Martin, A. [1 ]
机构：
[1] Univ Laval, CHU Quebec, Quebec City, PQ, Canada
[2] Univ Laval, CHU Quebec, Ctr Rech, Axe Oncol, Quebec City, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 158卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0101
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [31] LONG-TERM RESULTS OF HIGH-DOSE EBRT AND EBRT WITH BRACHYTHERAPY BOOST IN TREATMENT OF PROSTATE CANCER PATIENTS.
    Smolska-Ciszewska, B.
    Miszczyk, L.
    Bialas, B.
    Gawkowska-Suwinska, M.
    Plewicki, G.
    Fijalkowski, M.
    Giglok, M.
    Behrendt, K.
    Nowicka, E.
    Zajusz, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S286 - S286
  • [32] 10-year results in 1577 intermediate/high risk prostate cancer patients treated with external beam RT (EBRT) and hypofractionated high dose rate (HDR) brachytherapy boost
    Ghilezan, M.
    Galalae, R.
    Demanes, J.
    Schour, L.
    Gustafson, G.
    Nuemberg, N.
    Wallace, M.
    Martinez, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S83 - S84
  • [33] Preliminary analysis of HDR prostate brachytherapy in the management of patients with localized prostate cancer
    Springer, C
    Skeates, L
    Copps, C
    McKenzie, A
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S27 - S28
  • [34] Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone
    Kent, Aaron R.
    Matheson, Bronwyn
    Millar, Jeremy L.
    [J]. BRACHYTHERAPY, 2019, 18 (03) : 313 - 321
  • [35] MRI guided focal HDR brachytherapy in patients with localized prostate cancer
    Maenhout, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Koelink, M. R.
    Van Vliet-van den Ende, K. M.
    De Vries, J. H. W.
    Van Vulpen, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S154 - S154
  • [36] Primary Radiotherapy in non-metastatic Prostate Cancer - Retrospective Data Analysis EBRT plus HDR Brachytherapy versus EBRT alone
    Fischer, L. A.
    Hille, A.
    Knaus, O.
    Droege, L. H.
    Ziegler, D. A.
    Guhlich, M.
    Bendrich, S.
    Trojan, L.
    Strauss, A.
    Reichert, M.
    Puetsch, F.
    Braulke, F.
    Rieken, S.
    El Shafie, R.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S126 - S126
  • [37] External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Alonzi, Roberto
    Wylie, James
    Ahmed, Imtiaz
    Henry, Ann
    Heath, Catherine
    Hoskin, Peter J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (03): : 525 - 533
  • [38] THE IMPACT OF ANDROGEN-DEPRIVATION THERAPY ON CERAMIDES, A POTENTIAL BIOMARKER OF OUTCOMES OF PROSTATE CANCER FOR PATIENTS TREATED WITH EBRT AND HDR BRACHYTHERAPY BOOST
    Carignan, Damien
    Bourgeois, Marine
    Foster, William
    Martin, Andre-Guy
    Paris, Francois
    Vigneault, Eric
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S77 - S78
  • [39] Comparison of Long-term Outcomes for Patients with High-Risk Prostate Cancer Treated with EBRT Alone Versus Combination EBRT with a LDR Brachytherapy Boost
    Sanders, J.
    Peach, M. S.
    Schad, M. D.
    Bauer-Nilsen, K.
    Libby, B.
    Showalter, T. N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E306 - E306
  • [40] Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
    Moll, Matthias
    Magrowski, Lukasz
    Mittlboeck, Martina
    Heinzl, Harald
    Kirisits, Christian
    Ciepal, Jakub
    Masri, Oliwia
    Heilemann, Gerd
    Stando, Rafal
    Krzysztofiak, Tomasz
    Depowska, Gabriela
    d'Amico, Andrea
    Techmanski, Tomasz
    Kozub, Anna
    Majewski, Wojciech
    Suwinski, Rafal
    Wojcieszek, Piotr
    Sadowski, Jacek
    Widder, Joachim
    Goldner, Gregor
    Miszczyk, Marcin
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2024,
12345